Movemedical, a leading enterprise software platform for medical device inventory management, has announced a strategic investment partnership with Resurgens Technology Partners. This collaboration will provide essential capital to support Movemedical’s ongoing growth and expansion, advancing its mission to unify the medical device supply chain and foster innovation within the industry.
“As we grow, our focus on innovation and uniting the fragmented medical device supply chain remains paramount,” stated Bo Molocznik, Founder and CEO of Movemedical. “This investment will allow us to enhance our platform rapidly, ensuring we stay ahead while delivering exceptional value to our expanding customer base.”
Josh Weeks, President of Movemedical, shared his enthusiasm and vision for the company: “We are currently disrupting the industry with our technology, and this investment will enable us to scale even further. Our success stems from our talented team and industry experts dedicated to pushing boundaries and addressing complex supply chain challenges. With this partnership, we aim to continue leading for our customers and the industry.”
Movemedical plans to utilize the investment to grow its team and enhance capabilities across all business functions, aiming to accelerate the company’s global expansion while providing customers with real-time visibility, optimized inventory control, and seamless collaboration throughout the supply chain.
Danny Carpenter, Principal at Resurgens Technology Partners, remarked, “The inefficiencies and fragmentation within medical device supply chains add unnecessary costs and complexity to our healthcare system. We are excited to partner with the innovative team at Movemedical, along with their customers and partners, to transform these critical processes and enhance the quality and cost-effectiveness of global healthcare delivery.”
Adi Filipovic, Managing Director at Resurgens Technology Partners, added, “We aim to support companies we see as leaders in their markets, and we believe Movemedical is uniquely positioned to spearhead a transformation in how medical device supply chains are managed.”
This investment marks the tenth platform investment from Resurgens’ second fund, a $500 million vehicle that closed in 2022. Vedder Price advised Movemedical, while DLA Piper represented Resurgens in the transaction.
About Movemedical:
Movemedical provides comprehensive visibility and control over the manufacturing, storage, and distribution of medical devices. Supported by its long-standing clients, Movemedical aims to optimize inventory management, minimize waste, and enhance operational efficiency throughout the supply chain, allowing healthcare professionals and providers to focus on what matters most—patient care.
Movemedical’s enterprise software platform strives to set the gold standard for medical device inventory management, transforming the digital landscape through innovation, efficiency, and scalability. With seamless integration into enterprise systems, Movemedical accommodates both small and mid-sized companies without the need for custom configuration, while also addressing the complexities of larger enterprises. This positions the platform as a flexible and powerful solution that drives industry standards, promoting more efficient operations through transparency, data-driven decision-making, and advanced compliance features.
